Dow Jones
38.503,69 +263,71 (+0,69%) Nasdaq
15.696,64 +245,33 (+1,59%) Nikkei 225
37.552,16 +113,55 (+0,30%) EUR/USD
1,0705 +0,0049 (+0,46%) Bitcoin EUR
61.977,28 -152,19 (-0,24%) CMC Crypto 200
1.424,01 +9,25 (+0,65%)
Shockwave Medical, Inc. (SWAV)
Dopo ore:
| Chiusura precedente | 328,60 |
| Aperto | 328,62 |
| Denaro | 302,60 x 200 |
| Lettera | 355,52 x 200 |
| Min-Max giorno | 328,40 - 329,28 |
| Intervallo di 52 settimane | 157,00 - 331,58 |
| Volume | |
| Media Volume | 1.046.643 |
| Capitalizzazione | 12,323B |
| Beta (5 anni mensile) | 0,88 |
| Rapporto PE (ttm) | 85,56 |
| EPS (ttm) | 3,84 |
| Prossima data utili | 06 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 316,14 |
GlobeNewswireShockwave Medical to Livestream 2023 Investor Innovation Day
SANTA CLARA, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, will host an Investor Innovation Day on Monday, October 23, 2023, from 1:00 p.m to 4:00 p.m. Pacific Time. The Shockwave Investor Innovation Day will be held in hybrid format, in person in San Francisco and online as a simultaneous live webcast. Investors and other interested
- GlobeNewswire
Shockwave Medical Appoints Nick West as Associate Chief Medical Officer
Nick West, MD, joins Shockwave from Abbott VascularSANTA CLARA, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today that Nick West, MA, MD, FRCP, FESC, FACC, has joined the company in the role of Associate Chief Medical Officer. Dr. West will report to Keith Dawkins, MD, Chief Medical Officer, and will be based in Santa Cl
- GlobeNewswire
Shockwave Medical Announces Dan Puckett to Retire as CFO in 2024
SANTA CLARA, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today that Chief Financial Officer Dan Puckett plans to retire in the first quarter of 2024. Dan has served as the CFO at Shockwave since he joined the company in 2016. The Board of Directors has initiated a process to identify a successor. Mr. Puckett plans to con
